Publikace
- Carbonyl-reducing enzymes as targets of a drug-immobilised affinity carrier2015 | Farmaceutická fakulta v Hradci Králové
- Deeper Insight into the Reducing Biotransformation of Bupropion in the Human Liver2014 | Farmaceutická fakulta v Hradci Králové
- Isoquinoline alkaloids as a novel type of AKR1C3 inhibitors2014 | Farmaceutická fakulta v Hradci Králové
- Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro2013 | Farmaceutická fakulta v Hradci Králové
- Efficient isolation of carbonyl-reducing enzymes using affinity approach with anticancer drug oracin as a specific ligand2013 | Farmaceutická fakulta v Hradci Králové
- Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily2012 | Farmaceutická fakulta v Hradci Králové
- Enzyme stereospecificity as a powerful tool in searching for new enzymes2010 | Ústřední knihovna
- Partial purification and characterization of new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin2009 | Ústřední knihovna
- Partial purification and characterization of new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin2009 | Farmaceutická fakulta v Hradci Králové
- Reduction of anticancer drug doxorubicin by recombinant AKR1C3Publikace bez příslušnosti k fakultě
Loading network view...
